14-day Premium Trial Subscription Sign Up For FreeGet Free

Chembio Diagnostics Stock Forecast NASDAQ:CEMI

Price Target and Analyst Ratings

Most Recent Rating

On July 21, 2021 "Colliers Securities" gave "" rating for CEMI. The price target was set to $5.00+142.7%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-21 Downgraded by Colliers Securities $5.34 $5.00+142.7%
2021-03-11 Buy Reiterated by Colliers Securities $4.94 $8.00
2020-12-03 Hold - Buy Upgraded by Craig Hallum $7.51 $5.00 → $10.00
2020-12-03 Hold - Buy Upgraded by Craig Hallum $7.51
2020-11-06 Neutral - Buy Upgraded by Colliers Securities $4.74 $7.50
2020-11-06 Neutral - Buy Upgraded by Colliers Secur. $4.74 $7.50
2020-06-17 Buy - Neutral Downgraded by Colliers Secur. $3.89
2020-06-17 Hold Downgraded by Robert W. Baird $3.89 $4.00
2020-06-17 Buy - Hold Downgraded by Canaccord Genuity $3.89 $7.00
2020-06-17 Speculative Buy - Hold Downgraded by Benchmark $3.89
2020-06-17 Buy - Hold Downgraded by Craig Hallum $3.89 $8.00
2020-05-26 Outperform Initiated by Robert W. Baird $10.26 $21.00
2020-04-23 Buy Target Raised by Craig Hallum $15.11 $15.00 → $21.00
2020-04-15 Buy Reiterated by Canaccord Genuity $10.09 $12.00

CEMI Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -7.13% during the next 3 months and, with a 90% probability hold a price between $1.66 and $4.71 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-23 $1.78 $3.42 $5.07
2021-09-24 $1.78 $3.42 $5.06
2021-09-27 $1.77 $3.41 $5.06
2021-09-28 $1.76 $3.41 $5.05
2021-09-29 $1.76 $3.40 $5.04
2021-09-30 $1.75 $3.39 $5.04
2021-10-01 $1.74 $3.39 $5.03
2021-10-04 $1.74 $3.38 $5.02
2021-10-05 $1.73 $3.38 $5.02
2021-10-06 $1.73 $3.37 $5.01
2021-10-07 $1.72 $3.36 $5.01
2021-10-08 $1.71 $3.36 $5.00
2021-10-11 $1.71 $3.35 $4.99
2021-10-12 $1.70 $3.34 $4.99
2021-10-13 $1.70 $3.34 $4.98
2021-10-14 $1.69 $3.33 $4.98
2021-10-15 $1.68 $3.33 $4.97
2021-10-18 $1.68 $3.32 $4.96
2021-10-19 $1.67 $3.31 $4.96
2021-10-20 $1.66 $3.31 $4.95
2021-10-21 $1.66 $3.30 $4.94
2021-10-22 $1.65 $3.29 $4.94
2021-10-25 $1.65 $3.29 $4.93
2021-10-26 $1.64 $3.28 $4.93
2021-10-27 $1.63 $3.28 $4.92
2021-10-28 $1.63 $3.27 $4.91
2021-10-29 $1.62 $3.26 $4.91
2021-11-01 $1.61 $3.26 $4.90
2021-11-02 $1.61 $3.25 $4.89
2021-11-03 $1.60 $3.25 $4.89

About Chembio Diagnostics

Chembio Diagnostics Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company’s products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, which detect antibodies to HIV 1 and 2 wit... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT